Presentatör: Hans Jeppsson, CFO Presentation, datum och tid: 20 november kl 10:40 CET
Top line data on the ATTRACT study
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
MedNous article: A surprise finding in the clinic
Untangling the dualistic components of the RAS in PF the Yin and Yang
C21 shows promise against COVID-19 where other drugs have failed